[go: up one dir, main page]

KR860001105A - 2-벤질-4-(4-피리딜)티아졸의 제조방법 - Google Patents

2-벤질-4-(4-피리딜)티아졸의 제조방법 Download PDF

Info

Publication number
KR860001105A
KR860001105A KR1019850005279A KR850005279A KR860001105A KR 860001105 A KR860001105 A KR 860001105A KR 1019850005279 A KR1019850005279 A KR 1019850005279A KR 850005279 A KR850005279 A KR 850005279A KR 860001105 A KR860001105 A KR 860001105A
Authority
KR
South Korea
Prior art keywords
compound
alkyl
halo
general formula
hydrogen
Prior art date
Application number
KR1019850005279A
Other languages
English (en)
Inventor
에이. 불톤 데이비드 (외 3)
Original Assignee
제임스 에프. 나우프톤
머크 앤드 캄파니 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제임스 에프. 나우프톤, 머크 앤드 캄파니 인코포레이티드 filed Critical 제임스 에프. 나우프톤
Publication of KR860001105A publication Critical patent/KR860001105A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

내용 없음

Description

2―벤질―4―(4―피리딜)티아졸의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 하기 일반식(A)화합물을 산 또는 염기존재하에서 하기 일반식(B) 화합물과 반응시킨 다음 임의로 산화시키거나, 하기 일반식(C) 화합물을 강 염기 존재하에서 하기 일반식(D) 화합물과 반응시킨 다음 임의로 산환시킴을 특징으로 하여 하기 일반식(Ⅰ) 화합물 또는 이 약학적 염을 제조하는 방법.
    상기 식에서, R 및 R1은 독립적으로, (1)수소; (2) 할로; (3) 저급알콕시; (4) 저급알킬티오; (5) 저급알킬설피닐; (6) 저급알킬설포닐; (7) 비치환되거나 치환된 페닐 저급알콕시; (8) 저급알킬; (9) 저급알케닐; (10) 저급알카노일; (11) 할로저급알킬; (12) ―COORa(여기서 Ra는 H 또는 C1―5알킬이다): (13) 아릴; (14) 아릴옥시; 또는 아릴―s―; (15) 시아노; 916) 하이드록시저급알킬; (17) 할로저급알카노일; (18) 저급알카노이옥시; (19) 비치환되거나 치환된 헤테로아릴; (20) ―NRaCORb(여기서, Ra및 Rb는 독립적으로 H 또는 C1―6알킬이다); (21) ―NO2; (22) ―NRaRb; (23) ―ORa; (24) ―CONRaRb; (25) ―CORa; (26) ―NRaCONRaRb; (27) ―NRaCORb; (28) ―OCORa; (29) ―SCORa; 또는 (30) ―OCH2O―이고 R2는 단일 결합 또는 이중 결합으로 벤질탄소에 결합될 수 있고, 이중 결합일 경우 R2는 오로지 =O, =S, =NRa, 또는 =CH―Rc(여기서 Rc는 Ra, ORa또는 할로이다)일 수도 있고 단일 결합일 경우 한쌍 또는 두쌍의 R2가 존재할 수 있으며 각 R2는 독립적으로 R이고 R3는 Ra, 할로 또는 할로저급알킬이고 n은 1 내지 4이고 m은 1 내지 5이고 q는 0 또는 1이고 L은 이탈그룹, 예를 들어 할로, 토실 등이다.
  2. 제2항에 있어서, R 및 R1이 독립적으로 (1) 수소; (2) 할로; (3) ―ORa; (4) C1―6알킬티오; (5) C1―6알킬; (6) ―CF3; (7) 페닐; (8) ―CN; (9) ―NRaCORb; (10) ―NO2; (11) ―NRaRb; (12) ―CONRaRb; (13) ―NRaCONRbRb; 또는 (14) 헤테로아릴 또는 치환된 헤테로아릴이고 R2는 수소 또는 F이고 R3는 Ra이고 n은 1 또는 2이고 m은1또는 2이고 q는 0 또는 1인 일반식(Ⅰ) 화합물을 제조하는 방법.
  3. 제1항에 있어서, R 및 R1이 독립적으로 (1) 수소; (2) C1―6알킬; (3) ―NRaRb이고 R2는 수소 또는 F이고 R3는 H이고 n은 1 또는 2이고 m은 1 또는 2이고 q는 0 인 일반식(Ⅰ) 화합물을 제조하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019850005279A 1984-07-25 1985-07-24 2-벤질-4-(4-피리딜)티아졸의 제조방법 KR860001105A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/634,094 US4697012A (en) 1984-07-25 1984-07-25 Morpholino pyridyl thiazole compound
US634094 1984-07-25

Publications (1)

Publication Number Publication Date
KR860001105A true KR860001105A (ko) 1986-02-22

Family

ID=24542414

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850005279A KR860001105A (ko) 1984-07-25 1985-07-24 2-벤질-4-(4-피리딜)티아졸의 제조방법

Country Status (12)

Country Link
US (1) US4697012A (ko)
EP (1) EP0169502B1 (ko)
JP (1) JPS6137784A (ko)
KR (1) KR860001105A (ko)
AU (1) AU575666B2 (ko)
DE (1) DE3580317D1 (ko)
DK (1) DK336685A (ko)
ES (1) ES8700255A1 (ko)
GR (1) GR851809B (ko)
IL (1) IL75823A0 (ko)
PT (1) PT80833B (ko)
ZA (1) ZA855581B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149884B1 (en) * 1983-09-09 1992-12-16 Takeda Chemical Industries, Ltd. 5-pyridyl-1,3-thiazole derivatives, their production and use
GB9201692D0 (en) * 1992-01-27 1992-03-11 Smithkline Beecham Intercredit Compounds
WO1996037493A1 (de) * 1995-05-26 1996-11-28 Bayer Aktiengesellschaft Pyridyl-thiazole und deren verwendung zum schutz von pflanzen gegen befall durch mikroorganismen
WO2003106455A1 (en) 2002-06-14 2003-12-24 Applied Research Systems Ars Holding N.V. Azole methylidene cyanide derivatives and their use as protein kinase modulators
TWI336697B (en) * 2003-09-19 2011-02-01 Solvay Pharm Bv Thiazole derivatives as cannabinoid receptor modulators
US7294640B2 (en) 2004-02-06 2007-11-13 Merck & Co., Inc. Mitotic kinesin inhibitors
AR083023A1 (es) * 2010-09-17 2013-01-23 Purdue Pharma Lp Compuestos de piridina y una composicion farmaceutica que los comprende

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1112128A (en) * 1965-12-22 1968-05-01 Bellon Labor Sa Roger New thiazolyl-diphenylmethane derivatives
IL28803A (en) * 1966-11-18 1974-05-16 Wyeth John & Brother Ltd Oxazole and thiazole compounds,their preparation and pharmaceutical compositions containing them
CA962269A (en) * 1971-05-05 1975-02-04 Robert E. Grahame (Jr.) Thiazoles, and their use as insecticides
US4153703A (en) * 1977-06-30 1979-05-08 Uniroyal, Inc. Method of controlling insects and acarids with certain aryl-substituted thiazoles
EP0149884B1 (en) * 1983-09-09 1992-12-16 Takeda Chemical Industries, Ltd. 5-pyridyl-1,3-thiazole derivatives, their production and use

Also Published As

Publication number Publication date
DK336685D0 (da) 1985-07-24
JPS6137784A (ja) 1986-02-22
DE3580317D1 (en) 1990-12-13
ES8700255A1 (es) 1986-10-01
US4697012A (en) 1987-09-29
AU4532085A (en) 1986-01-30
AU575666B2 (en) 1988-08-04
ES545439A0 (es) 1986-10-01
EP0169502A2 (en) 1986-01-29
EP0169502A3 (en) 1987-02-25
IL75823A0 (en) 1985-11-29
GR851809B (ko) 1985-11-26
ZA855581B (en) 1986-03-26
EP0169502B1 (en) 1990-10-31
PT80833B (en) 1987-05-27
DK336685A (da) 1986-01-26
PT80833A (en) 1985-08-01

Similar Documents

Publication Publication Date Title
KR840004441A (ko) 포스포리피드 유도체의 제조방법
KR850006386A (ko) 아졸류의 제조방법
KR830005217A (ko) 이미다조 피리딘의 제조방법
UST984005I4 (en) Yellow-dye-forming couplers
DE3776391D1 (de) Fluessige zubereitungen von 1,2-benzisothiazolin-3-on, ihre herstellung und verwendung.
KR900016190A (ko) 2-페닐피리딘
KR860001105A (ko) 2-벤질-4-(4-피리딜)티아졸의 제조방법
KR840006475A (ko) 나프탈렌 유도체의 제조방법
KR860700250A (ko) 신규 아미딘 화합물
KR870000318A (ko) 2,6-이치환된 4-에폭시프로필페닐 글리시딜 에테르의 제조방법
KR840004065A (ko) 2-시아노-2-프로페노산 및 그 유도체의 제조방법
KR860002482A (ko) 디페닐 에테르 이민 유도체 제조방법
KR850003407A (ko) 유기인산 에스테르 유도체의 제조방법
KR900701746A (ko) 2-할로-4-알킬술포닐벤조산의 제조방법
KR880000377A (ko) 트란스 헥사하이드로 테레프탈산 에스테르 유도체의 제조방법
KR840006810A (ko) 세팔로스포린 에스테르의 제조방법
KR840005726A (ko) 고혈압 치료제로서 유용한 치환페닐 피페라진 화합물의 제조방법
KR850002095A (ko) 4,7-디히드로피라졸로[3,4-b] 피리딘 유도체의 제조방법
KR870008840A (ko) 1-스티렌술포닐-2-옥소-5-히드록시 피롤리딘 유도체의 제조방법
KR860000347A (ko) 벤조퀴논 유도체의 제조방법
KR850007800A (ko) 세팔로스포린 유도체의 에스테르 제조방법
KR830009044A (ko) 3,5-디-3급부틸-4-하이드록시페닐-치환 복소환 화합물의 제조방법
KR830005188A (ko) 혈당강하성 구아닐 아미딘의 제조방법
KR860004063A (ko) 알킬리덴 디옥시 화합물의 제조방법
KR840004759A (ko) 페니실린과 세팔로스포린 화합물의 제조방법 및 이들의 제조에 사용한 새로운 중간체의 제조방법

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19850724

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19861022

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19850724

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19880831

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19890106

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19880831

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I